Browse more on » Biotechnology, Survey, Polls & Research Research and Markets (http://www.researchandmarkets.com/research/rmhmmj/antiviral) has... ...http://www.indiaprwire.com/pressrelease/biotechnology/20140814329378.htm
MarketOptimizer.org adds OpportunityAnalyzer Graft-Versus-Host Disease Opportunity Analysis and Forecasts to 2018 to its store. The GVHD market... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=278369
From the Wires Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Aug. 21, 2014... ...http://in.sys-con.com/node/3157057
Press Release www.shire.com August 21, 2014 - Shire plc (the "Company") (LSE: SHP, NASDAQ: SHPG) is today publishing the audited consolidated... ...http://in.advfn.com/p.php?pid=nmona&article=63337963
Reuters (Reuters) - Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a... ...https://in.news.yahoo.com/long-acting-version-baxters-hemophilia-drug-succeeds-study-144230733--finance.html
Impressive Dental Care is a renowned...